The Hungarian life sciences, medical technology, and biotechnology sectors represent a highly concentrated, export-driven industry defined by a strong academic foundation and a transition from traditional pharmaceutical manufacturing to advanced digital health, medical deep tech, and artificial intelligence. The sector comprises approximately 150 to 180 export-driven medical device manufacturing enterprises, alongside around 90 biotechnology companies and a broader network of

Nelson Advisors have researched 20 future Healthtech and MedTech leaders in 20 European countries, highlighting the founders, scientists and technologists building innovative solutions and companies. In addition to the 20 x 20 Series, we have also predicted 3 HealthTech and MedTech hubs across Europe with the potential to become centres of excellence.

The landscape of Hungarian healthcare innovation has transitioned from a historical foundation of pharmaceutical excellence into a dynamic, multi-disciplinary ecosystem defined by medical deep tech, artificial intelligence and sophisticated biotechnology. This transformation is anchored by a strategic shift in the country’s academic and financial infrastructure, moving toward a "fourth-generation" research model where knowledge transfer and commercialization are prioritized a